AFMID and Alzheimer disease: In addition, by exploring the targets related to KF and AD through in silico analysis and proving the pharmacological efficacy of these, we were able to confirm the new physiological activity of KF, and we aim to suggest insightful results for the development of a new platform that can link natural products and targets and apply them to diseases.